IP Library Granted Patent US 10,962,554
Granted Patent B2
US 10,962,554 · App. 16/051,129 · Granted Mar 30, 2021

Diagnosis of a neurological disease

Inventors: Josep Dalmau (Barcelona, ES); Francesc Graus (Barcelona, ES)
Assignees: INSTITUT D'INVESTIGACIONES BIOMÈDIQUES AUGUST PI I SUNYER; INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS; UNIVERSITÄT DE BARCELONA; HOSPITAL CLÍNIC DE BARCELONA
G01N33/6896C07K16/2803G01N33/564G01N33/6854G01N2800/2814G01N2800/2821G01N2800/2864
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,962,554
App. No.
16/051,129
Granted
Mar 30, 2021
Kind
B2
Abstract

The present invention concerns subject matter connected to or making use of IgLON5, IgLON5 fragments and variants of IgLON5 and IgLON5-fragments. In particular the present invention relates to a use of a polypeptide comprising one or more sequences of IgLON5, an IgLON5-fragment or a variant thereof for the diagnosis of a disease, in vitro methods for diagnosing such a disease, a polypeptide comprising one or more sequences of IgLON5, an IgLON5-fragment or a variant thereof or a nucleic acid encoding said polypeptide for use in the treatment of a disease, a pharmaceutical composition comprising such polypeptide, a method for treating such a disease, an autoantibody binding to IgLON5, an IgLON5-fragment or a variant thereof, a method for isolating such autoantibody, a medical or diagnostic device comprising such autoantibody or such polypeptide and a test kit for the diagnosis of a disease, which test kit comprises such autoantibody and/or such polypeptide.

Claims (8)

1. A method of detecting an autoantibody to IgLON5 or a fragment thereof in a subject, the method comprising:

contacting a bodily fluid sample isolated from a subject with a polypeptide comprising IgLON5 or an IgLON5 fragment; and

detecting the presence or absence of an autoantibody to IgLON5 in a complex with the polypeptide,

wherein the IgLON5 comprises an amino acid sequence SEQ ID NO:1 or SEQ ID NO:12, and

wherein the IgLON5 fragment comprises an amino acid sequence selected from a group of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5; SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11.

2. The method of claim 1 , wherein the polypeptide is immobilized on a solid carrier.

3. The method of claim 1 , wherein the detecting the presence or absence of the autoantibody to IgLON5 in a complex with the polypeptide comprises the use of a tagged or labeled secondary antibody.

4. The method of claim 1 , wherein the polypeptide is provided in the form of a cell comprising a nucleic acid encoding the polypeptide or in the form of a tissue comprising the polypeptide.

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Aug 2, 2023
From: INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER; FUNDACIÓ CLÍNIC PER A LA RECERCA BIOMÈDICA
To: FUNDACIÓ DE RECERCA CLÍNIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER
Reel/Frame 064468/0758 →
ASSIGNMENT OF 50% INTEREST Recorded Aug 13, 2018
From: INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS
To: INSTITUT D'INVESTIGACIONES BIOMÈDIQUES AUGUST PI I SUNYER
Reel/Frame 046774/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2018
From: DALMAU, JOSEP
To: INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS
Reel/Frame 046564/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2018
From: GRAUS, FRANCESC
To: UNIVERSITAT DE BARCELONA; HOSPITAL CLÍNIC DE BARCELONA
Reel/Frame 046730/0265 →
Priority Claims (1)
EP 14154384 · Feb 7, 2014 · regional
Continuity (2)
Continuation 15116179
Related Publication 20180335439A1 · Nov 22, 2018